Suppr超能文献

生物风险和实验室获得性感染:健康生物技术中不容忽视的现实。

Biological Risks and Laboratory-Acquired Infections: A Reality That Cannot be Ignored in Health Biotechnology.

机构信息

Department of Veterinary Sciences, Veterinary and Animal Science Center (CECAV), School of Agrarian and Veterinary Sciences, University of Trás-os-Montes e Alto Douro , Vila Real , Portugal.

出版信息

Front Bioeng Biotechnol. 2015 Apr 28;3:56. doi: 10.3389/fbioe.2015.00056. eCollection 2015.

Abstract

Advances and research in biotechnology have applications over a wide range of areas, such as microbiology, medicine, the food industry, agriculture, genetically modified organisms, and nanotechnology, among others. However, research with pathogenic agents, such as virus, parasites, fungi, rickettsia, bacterial microorganisms, or genetic modified organisms, has generated concern because of their potential biological risk - not only for people, but also for the environment due to their unpredictable behavior. In addition, concern for biosafety is associated with the emergence of new diseases or re-emergence of diseases that were already under control. Biotechnology laboratories require biosafety measures designed to protect their staff, the population, and the environment, which may be exposed to hazardous organisms and materials. Laboratory staff training and education is essential, not only to acquire a good understanding about the direct handling of hazardous biological agents but also knowledge of the epidemiology, pathogenicity, and human susceptibility to the biological materials used in research. Biological risk can be reduced and controlled by the correct application of internationally recognized procedures such as proper microbiological techniques, proper containment apparatus, adequate facilities, protective barriers, and special training and education of laboratory workers. To avoid occupational infections, knowledge about standardized microbiological procedures and techniques and the use of containment devices, facilities, and protective barriers is necessary. Training and education about the epidemiology, pathogenicity, and biohazards of the microorganisms involved may prevent or decrease the risk. In this way, the scientific community may benefit from the lessons learned in the past to anticipate future problems.

摘要

生物技术的进步和研究在许多领域都有应用,例如微生物学、医学、食品工业、农业、转基因生物和纳米技术等。然而,对病原体(如病毒、寄生虫、真菌、立克次体、细菌微生物或转基因生物)的研究引起了人们的关注,因为它们具有潜在的生物风险——不仅对人类,而且对环境也有潜在的风险,因为它们的行为是不可预测的。此外,人们对生物安全的关注与新疾病的出现或已经得到控制的疾病的再次出现有关。生物技术实验室需要采取生物安全措施来保护其工作人员、公众和环境免受危险生物和材料的侵害。实验室工作人员的培训和教育至关重要,不仅要对直接处理危险生物制剂有很好的了解,还要了解所研究的生物材料的流行病学、致病性和人类易感性。通过正确应用国际公认的程序,如适当的微生物技术、适当的封闭装置、充足的设施、保护屏障以及对实验室工作人员的特殊培训和教育,可以降低和控制生物风险。为了避免职业感染,必须了解标准化的微生物程序和技术以及使用封闭设备、设施和保护屏障的知识。关于所涉及微生物的流行病学、致病性和生物危害的培训和教育,可以预防或降低风险。通过这种方式,科学界可以从过去的经验中吸取教训,预测未来的问题。

相似文献

1
Biological Risks and Laboratory-Acquired Infections: A Reality That Cannot be Ignored in Health Biotechnology.
Front Bioeng Biotechnol. 2015 Apr 28;3:56. doi: 10.3389/fbioe.2015.00056. eCollection 2015.
2
Improved Biosafety and Biosecurity Measures and/or Strategies to Tackle Laboratory-Acquired Infections and Related Risks.
Int J Environ Res Public Health. 2018 Nov 29;15(12):2697. doi: 10.3390/ijerph15122697.
3
[Biosafety risk of laboratory-acquired infection and countermeasures based on human factors].
Zhonghua Liu Xing Bing Xue Za Zhi. 2023 Aug 10;44(8):1309-1315. doi: 10.3760/cma.j.cn112338-20230214-00075.
4
Survey of laboratory-acquired infections around the world in biosafety level 3 and 4 laboratories.
Eur J Clin Microbiol Infect Dis. 2016 Aug;35(8):1247-58. doi: 10.1007/s10096-016-2657-1. Epub 2016 May 27.
8
The hidden face of academic researches on classified highly pathogenic microorganisms.
Infect Genet Evol. 2015 Jan;29:26-34. doi: 10.1016/j.meegid.2014.10.028. Epub 2014 Nov 7.
9
[Biosafety and biosecurity in the medical laboratory. Update and trends].
Bacteriol Virusol Parazitol Epidemiol. 2007 Jul-Dec;52(3-4):91-9.
10
Design and Construction of a Biosafety Level 3 Autopsy Laboratory.
Arch Pathol Lab Med. 2021 Apr 1;145(4):407-414. doi: 10.5858/arpa.2020-0644-SA.

引用本文的文献

1
A framework for biosafety assessment of microbial strains in Biotechnology applications.
Bioinformation. 2025 May 31;21(5):1158-1162. doi: 10.6026/973206300211158. eCollection 2025.
2
Occupational exposure monitoring of airborne respiratory viruses in outpatient medical clinics.
Aerosol Sci Technol. 2024 Oct 23. doi: 10.1080/02786826.2024.2403580.
5
A Systematized Overview of Published Reviews on Biological Hazards, Occupational Health, and Safety.
Saf Health Work. 2023 Dec;14(4):347-357. doi: 10.1016/j.shaw.2023.10.008. Epub 2023 Oct 21.
8
Effectiveness of international virtual training on biorisk management in the context of COVID-19.
Front Public Health. 2022 Oct 11;10:888097. doi: 10.3389/fpubh.2022.888097. eCollection 2022.
9
Safety in Medical Laboratories: Perception and Practice of University Students and Laboratory Workers.
Appl Biosaf. 2021 Sep;26(Suppl 1):S34-S42. doi: 10.1089/apb.20.0050. Epub 2021 Sep 13.

本文引用的文献

2
Gain-of-function experiments: time for a real debate.
Nat Rev Microbiol. 2015 Jan;13(1):58-64. doi: 10.1038/nrmicro3405. Epub 2014 Dec 8.
3
Human Brucella canis Infection and Subsequent Laboratory Exposures Associated with a Puppy, New York City, 2012.
Zoonoses Public Health. 2015 Aug;62(5):407-14. doi: 10.1111/zph.12163. Epub 2014 Nov 1.
6
Fatal meningococcal disease in a laboratory worker--California, 2012.
MMWR Morb Mortal Wkly Rep. 2014 Sep 5;63(35):770-2.
9
A One Health approach to the control of zoonotic vectorborne pathogens.
Vet Rec. 2014 Apr 19;174(16):398-402. doi: 10.1136/vr.g2539.
10
Immune control strategies for vaccinia virus-related laboratory-acquired infections.
Biomed Environ Sci. 2014 Feb;27(2):142-6. doi: 10.3967/bes2014.031.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验